Cornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer

Press/Media: Press / Media

PeriodJan 12 2015

Media coverage

45

Media coverage

  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletReuters
    CountryUnited Kingdom
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletBusinessWeek
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletMorningstar.com
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletIndividual.com
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletRCL Advisors
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletTown Hall
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletReliance Trust
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletSearchBug
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletSecurities Technology Monitor
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletFinancial Content
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletPettinga Financial Advisors
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletVision Monday
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletStreet Sweeper
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWall Street Business Network
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWall Street Select
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletMoneyShow.com
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletA.M. Best
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletBioSpace
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletTamar Securities
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outlet4 Traders
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletEMoneyDaily
    CountryUnited Kingdom
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletFinancial Content
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletTutorial Finder
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletConsumer Electronics Net
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletReview Seeker
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletPipelineReview
    CountrySpain
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletI Stock Analyst
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWGNT
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWGNT
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWGNT
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletU-T San Diego
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletStock Nod
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletAsk.com
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWGNT
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWGNT
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletWGNT
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletGlobeNewswire
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletBizWire Express
    CountryIndia
    Date1/12/15
    PersonsAngela Alistar
  • TitleCornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer
    Media name/outletVirtual Strategy Magazine
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar